Unal, O. U. Et Al. 2014. Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15 , 6165-6169.

Unal, O. U., Yilmaz, A. U., YAVUZŞEN, T., Akman, T., & ELLİDOKUZ, H., (2014). Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, 6165-6169.

Unal, Olcun Et Al. "Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, 6165-6169, 2014

Unal, Olcun U. Et Al. "Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, pp.6165-6169, 2014

Unal, O. U. Et Al. (2014) . "Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.15, pp.6165-6169.

@article{article, author={Olcun Umit Unal Et Al. }, title={Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2014, pages={6165-6169} }